Carl Icahn
Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
Icahn has successfully pushed for changes at Time Warner (NYSE: TWX) and Temple-Inland (NYSE: TIN), among others. Icahn won board seats at Motorola (NYSE: MOT) after first failing.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
In early, 2008 Icahn activist target BEA Systems (Nasdaq: BEAS) was sold to Oracle (Nasdaq: ORCL). Icahn held a 13% stake in BEA.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
-
-
-
-
-
-
-
Carl Icahn trims Cheniere Energy (LNG) in Q4 - 13F
-
-
-
-
-
-
-
Xerox Corp. (XRX) on Watch on Renewed Chatter
-
-
-
-
-
-
-
Form 4 Xerox Holdings Corp For: Mar 04 Filed by: ICAHN PARTNERS LP
-
-
-
-
-
-
-
Form SC 13D/A Xerox Holdings Corp Filed by: ICAHN CARL C
-
-
-
-
-
-
-
Carl Icahn boosts Xerox stake to over 14%
-
-
-
-
-
-
-
XORTX Files U.S. FDA Pre-IND Meeting Request for XRx-101 (Oxypurinol) COVID-19 Program and Pre-IND Meeting Submission
-
-
-
-
-
-
-
XORTX Partners with Mount Sinai’s Icahn School of Medicine on US-based Clinical Trial in COVID-19
-
11,332 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All